Bioequivalence study of a generic risperidone (Iperdal®) in healthy Thai male volunteers

Songklanakarin Journal of Science and Technology

Volumn 30, Issue 3, 2008, Pages 307-312

  Mahatthanatrakul, Werawath ^a   Nontaput, Tharinee ^b   Sriwiriyajan, Somchai ^a   Ridtitid, Wibool ^a   Wongnawa, Malinee ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b Boromarajonani Songkhla Nursing College   (Thailand)

Author keywords

Bioequivalence; Iperdal ; Risperdal ; Risperidone

Indexed keywords

EID: 55349097509     PISSN: 01253395     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Avenoso, A., Facciola, G., Salemi, M. and Spina, E. 2000. Determination of risperidone and its major metabolite 9-hydroxyrisperidone in human plasma by reversephase liquid chromatography with ultraviolet detection. Journal of Chromatography B. 746, 173-181.
2. Cho, H.Y. and Lee, Y.B. 2006. Pharmacokinetics and Bioequivalence Evaluation of Risperidone in Healthy Male Subjects with Different CYP2D6 Genotypes. Archives of Pharmacal Research. 29 (6), 525-533.
3. Food and Drug Administration 1992. FDA guidance: statistical procedures for bioequivalence studies using a standard two-treatment cross-over design. Food and Drug Administration, Washington DC.
4. Guidance for Industry: Bioanalytical Method Validation. 2001. U.S. Food and Drug Administration, Criteria for Drug Evaluation and Research.
5. Heykants, J., Huang M.L., Mannens G et al. 1994. The pharmacokinetics of risperidone in humans: A Summary. Journal of Clinical Psychiatry. 55, 13-17.
6. Huang, M.L., Van, Peer A., Woestenborghs, R., de Coster, R., Heykants, J., Jansen, A.A., et al. 1993. Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in the healthy subjects. Journal of Clinical Pharmacology and Therapeutics. 54, 257-268.
7. Hunt,CM.,Westerkam,WR., Stave, GM.1992. Effects of age and gender on the activity of human hepatic CYP3A. Biochemical Pharmacology. 44, 275-283.
8. Marder, SR., Davis, JM., Chouinard, G. 1997. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis : Combined results of the North American Trials. Journal of Clinical Psychiatry. 58(12), 538-546.
9. 2 and dopamine-D2 receptor occupancy in the living human brain. Psychopharmacology. 110, 265-272.
10. Thai Food and Drug Administration (FDA). 2006. Criteria and guideline for the bioequivalence study of generic drug.
11. RxList 2008. Risperdal. http://www.rxlist.com/cgi/generic/ risperid.htm [March 5, 2008]